GMT — Genomtec SA Income Statement
0.000.00%
Last trade - 00:00
- PLN163.03m
- PLN157.98m
- PLN0.04m
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | PRESS | ARS |
Standards: | PAS | IFRS | — | IFRS |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 0.153 | 0.02 | 0.219 | 0.04 |
Cost of Revenue | ||||
Gross Profit | -0.122 | -3.51 | -0.455 | -3.23 |
Selling / General / Administrative Expenses | ||||
Depreciation and Amortization | ||||
Other Operating Expenses | ||||
Total Operating Expenses | 1.71 | 10.9 | 5.86 | 11.5 |
Operating Profit | -1.56 | -10.9 | -5.64 | -11.5 |
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | -1.57 | -10.9 | -5.75 | -11.9 |
Provision for Income Taxes | ||||
Net Income After Taxes | -1.45 | -10.9 | -5.27 | -11.9 |
Net Income Before Extraordinary Items | ||||
Net Income | -1.45 | -10.9 | -5.27 | -11.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | -1.45 | -10.9 | -5.27 | -11.9 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | -0.177 | -1.34 | -0.646 | -1.27 |
Dividends per Share |